AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab...

6

Transcript of AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab...

Page 1: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is
Page 2: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is
Page 3: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is
Page 4: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is
Page 5: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is
Page 6: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is